Could China's coronavirus outbreak hurt the global drug industry?
Elize Mak of Al Jazeera reports on the concerns of possible shortages of antibiotics following the coronavirus outbreak. Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, is quoted on the impact that the virus could have on the global supply of these lifesaving products.
The article uncovers the possibility of global antibiotic shortages if manufacturers of key ingredients in China remain affected by government measures to contain the virus.
Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation is quoted in the article:
"It would be very difficult for a foreign buyer to replace Chinese API supplies in the event of a disruption - at least not quickly. What's more patients are typically given inferior drugs during shortages."